Refractory severe type B insulin resistance treated with daratumumab

Samhitha Munugoti, Maneesh Gaddam, Natasha Rasool, Pavel Shevtsov, Paramarajan Piranavan, Philip A Kern · 2026

Read Refractory severe type B insulin resistance treated with daratumumab by Samhitha Munugoti, Maneesh Gaddam, Natasha Rasool, Pavel Shevtsov, Paramarajan Piranavan, Philip A Kern (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13213080.txt.

Description

Samhitha Munugoti and co-authors recount in 2026 an extreme case of autoimmune insulin resistance in a 24-year-old man. Antibodies attacked his insulin receptors, and at the peak he needed staggering daily insulin doses while also developing newly discovered lupus.

Standard immune treatments followed one after another, including steroids, several antibody drugs, blood plasma exchange, and immune globulin, yet resistance persisted because long-lived plasma cells kept making the harmful antibodies. A drug aimed at those plasma cells finally turned the course. Insulin needs fell steadily, and seventeen months after he arrived he stopped insulin altogether with normal blood sugar control. The case argues for plasma-cell targeting when usual therapy fails.

Catalog record

CREATORSamhitha Munugoti, Maneesh Gaddam, Natasha Rasool, Pavel Shevtsov, Paramarajan Piranavan, Philip A Kern
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE18 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13213080

Browse the full library · About the Tower of Babel